日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Performance of Elecsys Anti-HEV IgG and IgM Assays for the Detection of Acute, Recent or Past Hepatitis E Virus Infection

Elecsys抗HEV IgG和IgM检测方法在检测急性、近期或既往戊型肝炎病毒感染中的性能

Schemmerer, Mathias; Pflüger, Lisa Sophie; Schneider, Tanja; Lu, Jie; Kienle, Korbinian; Meyer-Schlinkmann, Kristin Maria; Mühlbacher, Annelies; Polz, Johannes; Schennach, Harald; Xie, Qing; Voitenleitner, Christian; Wenzel, Jürgen; Lütgehetmann, Marc

Toll-Like Receptor 8 Agonist GS-9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B

Toll样受体8激动剂GS-9688在土拨鼠慢性乙型肝炎模型中诱导持续疗效

Daffis, Stephane; Balsitis, Scott; Chamberlain, Jason; Zheng, Jim; Santos, Rex; Rowe, William; Ramakrishnan, Dhivya; Pattabiraman, Divya; Spurlock, Sandra; Chu, Ruth; Kang, Don; Mish, Michael; Ramirez, Ricardo; Li, Li; Li, Bei; Ma, Sarina; Hung, Magdeleine; Voitenleitner, Christian; Yon, Changsuek; Suresh, Manasa; Menne, Stephan; Cote, Paul; Delaney, William E 4th; Mackman, Richard; Fletcher, Simon P

Woolly Monkey-HBV Infection in Squirrel Monkeys as a Surrogate Nonhuman Primate Model of HBV Infection

松鼠猴中的绒毛猴-HBV 感染作为 HBV 感染的非人类灵长类动物替代模型

Christopher Y Chen, Benjamin Y Winer, Deborah Chavez, Bernadette Guerra, Kathleen M Brasky, Stacey Eng, Eduardo Salas, Danny Tam, Joe H Simmons, Christian R Abee, William E Delaney, Alexander Ploss, Robert E Lanford, Christian Voitenleitner

Design of N-Benzoxaborole Benzofuran GSK8175-Optimization of Human Pharmacokinetics Inspired by Metabolites of a Failed Clinical HCV Inhibitor

受失败的临床HCV抑制剂代谢产物启发,设计N-苯并噁硼杂环苯并呋喃GSK8175——优化人体药代动力学

Chong, Pek Y; Shotwell, J Brad; Miller, John; Price, Daniel J; Maynard, Andy; Voitenleitner, Christian; Mathis, Amanda; Williams, Shawn; Pouliot, Jeffrey J; Creech, Katrina; Wang, Feng; Fang, Jing; Zhang, Huichang; Tai, Vincent W-F; Turner, Elizabeth; Kahler, Kirsten M; Crosby, Renae; Peat, Andrew J

Spatiotemporal Analysis of Hepatitis B Virus X Protein in Primary Human Hepatocytes

人原代肝细胞中乙肝病毒X蛋白的时空分析

Dmytro Kornyeyev, Dhivya Ramakrishnan, Christian Voitenleitner, Christine M Livingston, Weimei Xing, Magdeleine Hung, Hyock Joo Kwon, Simon P Fletcher #, Rudolf K Beran #

Nucleotide Prodrug Containing a Nonproteinogenic Amino Acid To Improve Oral Delivery of a Hepatitis C Virus Treatment

含有非蛋白源性氨基酸的核苷酸前药可改善丙型肝炎病毒治疗药物的口服递送

Feng, Joy Y; Wang, Ting; Park, Yeojin; Babusis, Darius; Birkus, Gabriel; Xu, Yili; Voitenleitner, Christian; Fenaux, Martijn; Yang, Huiling; Eng, Stacey; Tirunagari, Neeraj; Kirschberg, Thorsten; Cho, Aesop; Ray, Adrian S

Cell-Free Hepatitis B Virus Capsid Assembly Dependent on the Core Protein C-Terminal Domain and Regulated by Phosphorylation

无细胞乙型肝炎病毒衣壳组装依赖于核心蛋白C端结构域并受磷酸化调控

Ludgate, Laurie; Liu, Kuancheng; Luckenbaugh, Laurie; Streck, Nicholas; Eng, Stacey; Voitenleitner, Christian; Delaney, William E 4th; Hu, Jianming

Preclinical characterization of GSK2336805, a novel inhibitor of hepatitis C virus replication that selects for resistance in NS5A

GSK2336805 是一种新型丙型肝炎病毒复制抑制剂,可诱导 NS5A 耐药性的选择,本文对其进行了临床前表征。

Walker, Jill; Crosby, Renae; Wang, Amy; Woldu, Ermias; Vamathevan, Jessica; Voitenleitner, Christian; You, Shihyun; Remlinger, Katja; Duan, Maoshang; Kazmierski, Wieslaw; Hamatake, Robert

Clinical and in vitro resistance to GS-9669, a thumb site II nonnucleoside inhibitor of the hepatitis C virus NS5B polymerase

临床和体外对GS-9669(一种针对丙型肝炎病毒NS5B聚合酶拇指位点II的非核苷类抑制剂)的耐药性

Dvory-Sobol, Hadas; Voitenleitner, Christian; Mabery, Eric; Skurnac, Taylor; Lawitz, Eric J; McHutchison, John; Svarovskaia, Evguenia S; Delaney, William; Miller, Michael D; Mo, Hongmei

In vitro characterization of GSK2485852, a novel hepatitis C virus polymerase inhibitor

体外表征新型丙型肝炎病毒聚合酶抑制剂GSK2485852

Voitenleitner, Christian; Crosby, Renae; Walker, Jill; Remlinger, Katja; Vamathevan, Jessica; Wang, Amy; You, Shihyun; Johnson, John 3rd; Woldu, Ermias; Van Horn, Stephanie; Horton, Joseph; Creech, Katrina; Shotwell, J Brad; Hong, Zhi; Hamatake, Robert